Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 3
2005 3
2006 2
2007 4
2008 4
2009 4
2010 3
2011 10
2012 4
2013 5
2014 1
2015 1
2016 2
2017 4
2018 3
2019 1
2020 6
2021 5
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Carbon-neutral pathway to mitigating transport-power grid cross-sector effects.
Ma J, Kong H, Wang J, Zhong H, Li B, Song J, Kammen DM. Ma J, et al. Among authors: kammen dm. Innovation (Camb). 2024 Mar 12;5(3):100611. doi: 10.1016/j.xinn.2024.100611. eCollection 2024 May 6. Innovation (Camb). 2024. PMID: 38586280 Free PMC article. Review. No abstract available.
Deploy diverse renewables to save tropical rivers.
Schmitt RJP, Kittner N, Kondolf GM, Kammen DM. Schmitt RJP, et al. Among authors: kammen dm. Nature. 2019 May;569(7756):330-332. doi: 10.1038/d41586-019-01498-8. Nature. 2019. PMID: 31092945 No abstract available.
An action agenda for Africa's electricity sector.
Puig D, Moner-Girona M, Kammen DM, Mulugetta Y, Marzouk A, Jarrett M, Hailu Y, Nakićenović N. Puig D, et al. Among authors: kammen dm. Science. 2021 Aug 6;373(6555):616-619. doi: 10.1126/science.abh1975. Science. 2021. PMID: 34353936 No abstract available.
Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development.
Boxer AL, Gold M, Huey E, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian Z, Sutherland M, Farese R, Miller BL, Cummings J. Boxer AL, et al. Among authors: van kammen d. Alzheimers Dement. 2013 Mar;9(2):176-88. doi: 10.1016/j.jalz.2012.03.002. Epub 2012 Oct 5. Alzheimers Dement. 2013. PMID: 23043900 Free PMC article. Review.
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: the next therapeutic frontier).
Boxer AL, Gold M, Huey E, Hu WT, Rosen H, Kramer J, Gao FB, Burton EA, Chow T, Kao A, Leavitt BR, Lamb B, Grether M, Knopman D, Cairns NJ, Mackenzie IR, Mitic L, Roberson ED, Van Kammen D, Cantillon M, Zahs K, Jackson G, Salloway S, Morris J, Tong G, Feldman H, Fillit H, Dickinson S, Khachaturian ZS, Sutherland M, Abushakra S, Lewcock J, Farese R, Kenet RO, Laferla F, Perrin S, Whitaker S, Honig L, Mesulam MM, Boeve B, Grossman M, Miller BL, Cummings JL. Boxer AL, et al. Among authors: van kammen d. Alzheimers Dement. 2013 Mar;9(2):189-98. doi: 10.1016/j.jalz.2012.03.003. Epub 2012 Oct 10. Alzheimers Dement. 2013. PMID: 23062850 Free PMC article. Review.
Natural history of Huntington disease.
Dorsey ER, Beck CA, Darwin K, Nichols P, Brocht AF, Biglan KM, Shoulson I; Huntington Study Group COHORT Investigators. Dorsey ER, et al. JAMA Neurol. 2013 Dec;70(12):1520-30. doi: 10.1001/jamaneurol.2013.4408. JAMA Neurol. 2013. PMID: 24126537
74 results